# Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes

Study · id `cardio:ct-nct07102628` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07102628](<https://clinicaltrials.gov/study/NCT07102628>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07102628

Browse, organ or system: Heart; Metabolism  
Browse, condition area: Risk and prevention; Coronary and vascular disease; Diabetes and metabolic disease; Acute care and long-term living  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 305 participants.

## Technical summary

Registry record NCT07102628. Randomized; quadruple masking; primary purpose treatment. Start 2025-10-03 (actual); primary completion 2027-01-16 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 305 participants (enrolled count; ClinicalTrials.gov record NCT07102628, source copy `cardio:ctgov-nct07102628-2026-11-17`, retrieved 2026-11-18)
- Started: 2025-10-03 (actual) (ClinicalTrials.gov record NCT07102628, source copy `cardio:ctgov-nct07102628-2026-11-17`, retrieved 2026-11-18)
- Primary completion: 2027-01-16 (anticipated) (ClinicalTrials.gov record NCT07102628, source copy `cardio:ctgov-nct07102628-2026-11-17`, retrieved 2026-11-18)
- Completion: 2027-01-16 (anticipated) (ClinicalTrials.gov record NCT07102628, source copy `cardio:ctgov-nct07102628-2026-11-17`, retrieved 2026-11-18)
- Countries: Australia; Canada; China; France; Germany; Hong Kong SAR China; Hungary; India; Japan; Poland; South Korea; Spain; Switzerland (ClinicalTrials.gov record NCT07102628, source copy `cardio:ctgov-nct07102628-2026-11-17`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07102628-2026-11-17`, retrieved 2026-11-18)

## The registry's words

- Brief title: Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes
- Acronym: ACS
- Condition: Acute Coronary Syndrome
- Intervention (Drug): Placebo
- Intervention (Drug): Inclisiran
- Lead sponsor: Novartis Pharmaceuticals
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: Non-ST-elevation heart attack (NSTEMI) (`cardio:nstemi`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry intervention name matches this record: Inclisiran (`cardio:inclisiran`)
- Registry lists this organization as the lead sponsor: Novartis (`cardio:novartis`)

## Provenance

Content hash: b59bb8c6be8d8ce174ea0ceaf49f86d8ef3122b42834212701f57c3276d67366
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
